HLA-DQA1 and HLA-DQB1 Gene Polymorphism in Indonesian Children with Type I Diabetes Mellitus

References

• Yahaya T, Salisu T. Genes predisposing to type 1 diabetes mellitus and pathophysiology: a narrative review. arXiv preprint. 2020;29(1):100–109.
   Google Scholar
• Regnell SE, Lernmark Å. Early prediction of autoimmune (type 1) diabetes. Diabetologia. 2017;60(type 1):1370–1381. doi:10.1007/s00125-017-4308-1
   PubMed Web of Science ®Google Scholar
• Hanscombe KB, Morris DL, Noble JA, Dilthey AT. Genetic fine mapping of Systemic Lupus Erythematosus MHC associations in Europeans and African Americans. Human Mol Genetics. 2018;(August):1–46.
   PubMedGoogle Scholar
• Jahromi M. Review article Human Leukocyte Antigen (HLA) and islet autoantibodies are tools to characterize type 1 diabetes in Arab countries: emphasis on Kuwait. Disease Markers. 2019;2019(Table 1):9786078.
   PubMedGoogle Scholar
• Rohana AG, Loh KC, Tin SK, et al. HLA-DQ A1, -DQB1 and -DRB1 gene polymorphism--in Malay type 1 diabetes mellitus patients and their use for riskprediction. Med J Malaysia. 2011;66(2):133-137.
   Google Scholar
• Gabbay MAL, Sato MN, Duarte AJS, Dib SA. Serum titres of anti-glutamic acid decarboxylase- 65 and anti-IA- 2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients. Clin Exp Immunol. 2011;168:60–67.
   Web of Science ®Google Scholar
• Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383(9911):69–82. doi:10.1016/S0140-6736(13)60591-7
   PubMed Web of Science ®Google Scholar
• Thirunavukkarasu R, Asirvatham AJ, Chitra A. SLC30A8 gene rs13266634 C/T polymorphism in children with Type 1 diabetes in Tamil Nadu. India. 2019;11(1):55–60.
   Google Scholar
• Singh S, Singh G, Agrawal NK, Ab Z. Prevalence of autoantibodies and HLA DR, DQ in Type 1 diabetes mellitus. J Clin Diagn Res. 2016;10:9–13.
   Google Scholar
• Chan J, Yeung V, Chow C, et al. Pancreatic p cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus. Diabetes Research and Clinical Practice. 1996;32(1–2):27–34. doi:10.1016/0168-8227(96)01203-x
   PubMed Web of Science ®Google Scholar
• Ahmed N, Khan J, Siddiqui T. Frequency of dyslipidaemia in type 2 diabetes mellitus in patients of Hazara division frequency of dyslipidaemia in Type 2 diabetes mellitus in patients of hazara division Nasir Ahmed, Jahangir Khan, Tahir Saeed Siddiqui *. J Ayub Med Coll Abbottabad. 2014;20(2):51–54.
   Google Scholar
• Wenzlau JM, Liu Y, Yu L, et al. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in Type 1 diabetes. Diabetes. 2008;57(10):2693–2697. doi:10.2337/db08-0522
   PubMed Web of Science ®Google Scholar
• Ikegami H, Kawaguchi Y, Yamato E, et al. Analysis by the polymerase chain reaction of histocompatibility leucocyte antigen-DRS-linked susceptibility to insulin-dependent diabetes mellitus. J Clin Endocrinol Metabol. 1992;75(November):1381–1385. doi:10.1210/jcem.75.5.1358911
   PubMedGoogle Scholar
• Ettinger RA, Liu AW, Nepom GT, Kwok WW. Beta 57-Asp plays an essential role in the unique SDSstability of HLA- DQA1*0102/ DQB1*0602 alpha beta protein dimer, the class II MHC allele associatedwith protection from insulin-dependent diabetes mellitus. J Immunol. 2000;165(6):3232-3238. doi:10.4049/jimmunol.165.6.3232
   Google Scholar
• Sperling MA, Tamborlane WV, Bettelino T, Weinzimer SA, Philip M. Diabetes mellitus. In: MA Sperling (ed.) Pediatric Endocrinology, 4th edn.Philadelphia:Elsevier Saunders; 2014:846-900.
   Google Scholar
• Dudek NL, Purcell AW. The beta cell immunopeptidome. Beta Cell. 2014;95:115–144.
   Web of Science ®Google Scholar
• Van Lummel M, Van Veelen PA, De Ru AH, et al. Discovery of a selective islet peptidome presented by the highest-risk HLA-DQ8 trans Molecule. Diabetes. 2016;65:732–741.
   PubMed Web of Science ®Google Scholar
• Noble JA. Immunogenetics of type 1 diabetes: a comprehensive review. J Autoimmun. 2015;64:101–112. doi:10.1016/j.jaut.2015.07.014
   PubMed Web of Science ®Google Scholar
• Robertson CC, Rich SS. Genetics of type 1 diabetes. Curr Opin Genet Dev. 2018;50(Figure 1):7–16. doi:10.1016/j.gde.2018.01.006
   PubMed Web of Science ®Google Scholar
• Sayad A, Ph D, Akbari MT, Ph D, Pajouhi M. Investigation the role of gender on the HLA-DRB1 and -DQB1 association with Type 1 diabetes mellitus in Iranian patients. Cell Journal. 2013;15(2):108–115.
   PubMed Web of Science ®Google Scholar
• Kawabata Y, Ikegami H, Kawaguchi Y, et al. The contribution of HLA-DR and -DQ haplotypes to susceptibility to Type 1 diabetes. Diabetes. 2002;51(2):545–551. doi:10.2337/diabetes.51.2.545
   PubMed Web of Science ®Google Scholar
• Stayoussef M, Benmansour J, Al-jenaidi FA, et al. Influence of common and specific HLA-DRB1/DQB1 haplotypes on genetic susceptibilities of three distinct Arab populations to Type 1 diabetes mellitus. Clin Vaccine Immunol. 2009;16(1):136–138. doi:10.1128/CVI.00215-08
   PubMed Web of Science ®Google Scholar
• Hamzeh AR, Al Ali MT, Al-Khaja N, Al Ali MT. Association of HLA-DQA1 and -DQB1 alleles with type I diabetes in Arabs: a meta-analyses. Tissue Antigens. 2015;86(1):21–27. doi:10.1111/tan.12598
   PubMedGoogle Scholar
• Jahromi MM, Eisenbarth GS. Genetic Determinants of Type 1 Diabetes. Vol. 299. IntechOpen2006; 289–299.
   Google Scholar
• Zhang L, Gianani R, Nakayama M, Liu E, Kobayashi M. Type 1 diabetes: chronic progressive autoimmune disease. Novartis Found Symp. 2008;92:85–98.
   Google Scholar
• Nakanishi K, Inoko H. Combination of HLA-A24, -DQA1*03, and -DR9 contributes to acute-onsetand early complete β-cell destruction in type 1 diabetes: Longitudinal study of residual β-cell function. American Diabetes Association. 2006;55(6):1862–1868. Available from: https:// diabetesjournals.org/ diabetes/article/55/6/1862/15545/Combination-of-HLA-A24-DQA1-03-and-DR9-Contributes. Accessed December 30, 2021.
   Google Scholar
• Pradana KA, Widjaya MA, Wahjudi M. Indonesians Human Leukocyte Antigen (HLA) distributions and correlations with global diseases. Immunol Invest. 2020;49(3):333–363. doi:10.1080/08820139.2019.1673771.
   PubMed Web of Science ®Google Scholar
• Shojaeian A. An overview of the epidemiology of Type 1 diabetes mellitus. Int J Metab Syndr. 2020;2:1–5.
   Google Scholar
• Katsarou A, Gudbjörnsdottir S, Rawshani A, et al. Type 1 diabetes mellitus. Nat Publ Gr. 2017;3:1–18.
   Google Scholar
• Gregg B, Connor CG, Ruedy KJ, et al. Body mass index changes in youth in the first year after Type 1 diabetes diagnosis. J Pediatr. 2015;166(5):1265–1269.e1. doi:10.1016/j.jpeds.2015.02.036
   PubMed Web of Science ®Google Scholar
• De Keukelaere M, Fieuws S, Reynaert N, et al. Evolution of body mass index in children with type 1 diabetes mellitus. Eur J Ped. 2018. 177(11):1661
   PubMed Web of Science ®Google Scholar